CAPTRUST Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $372M | Buy |
1,711,395
+223,446
| +15% | +$49.6M | 0.65% | 25 |
|
|
2025
Q4 | $340M | Buy |
1,487,949
+13,113
| +0.9% | +$2.99M | 0.65% | 29 |
|
|
2025
Q3 | $341M | Buy |
1,474,836
+38,309
| +3% | +$7.8M | 0.7% | 30 |
|
|
2025
Q2 | $267M | Buy |
1,436,527
+51,551
| +4% | +$9.58M | 0.59% | 32 |
|
|
2025
Q1 | $290M | Buy |
1,384,976
+89,679
| +7% | +$17.4M | 0.73% | 30 |
|
|
2024
Q4 | $230M | Buy |
1,295,297
+66,432
| +5% | +$12.2M | 0.66% | 31 |
|
|
2024
Q3 | $243M | Buy |
1,228,865
+61,104
| +5% | +$11.4M | 0.72% | 29 |
|
|
2024
Q2 | $200M | Buy |
1,167,761
+241,477
| +26% | +$40M | 0.64% | 32 |
|
|
2024
Q1 | $169M | Sell |
926,284
-35,080
| -4% | -$6.05M | 0.62% | 32 |
|
|
2023
Q4 | $149M | Buy |
961,364
+110,849
| +13% | +$16.2M | 0.51% | 39 |
|
|
2023
Q3 | $127M | Buy |
850,515
+43,111
| +5% | +$6.33M | 0.48% | 42 |
|
|
2023
Q2 | $109M | Buy |
807,404
+64,273
| +9% | +$9.43M | 0.43% | 48 |
|
|
2023
Q1 | $118M | Buy |
743,131
+47,205
| +7% | +$7.22M | 0.52% | 39 |
|
|
2022
Q4 | $112M | Buy |
695,926
+34,285
| +5% | +$5.26M | 0.57% | 37 |
|
|
2022
Q3 | $88.8M | Buy |
661,641
+98,200
| +17% | +$14.1M | 0.52% | 37 |
|
|
2022
Q2 | $86.3M | Buy |
563,441
+72,802
| +15% | +$11.1M | 0.56% | 35 |
|
|
2022
Q1 | $79.5M | Buy |
490,639
+32,588
| +7% | +$4.73M | 0.51% | 37 |
|
|
2021
Q4 | $62M | Buy |
458,051
+51,338
| +13% | +$6.06M | 0.43% | 49 |
|
|
2021
Q3 | $43.9M | Buy |
406,713
+66,561
| +20% | +$7.61M | 0.36% | 65 |
|
|
2021
Q2 | $38.3M | Buy |
340,152
+18,536
| +6% | +$2.09M | 0.36% | 65 |
|
|
2021
Q1 | $34.8M | Buy |
321,616
+35,298
| +12% | +$3.78M | 0.38% | 62 |
|
|
2020
Q4 | $30.7M | Buy |
286,318
+16,559
| +6% | +$1.59M | 0.41% | 58 |
|
|
2020
Q3 | $23.5M | Sell |
269,759
-7,738
| -3% | -$729K | 0.39% | 55 |
|
|
2020
Q2 | $27.5M | Buy |
277,497
+34,236
| +14% | +$3.01M | 0.45% | 55 |
|
|
2020
Q1 | $17.9M | Buy |
243,261
+80,026
| +49% | +$6.82M | 0.39% | 67 |
|
|
2019
Q4 | $14.6M | Buy |
163,235
+102,827
| +170% | +$8.54M | 0.23% | 112 |
|
|
2019
Q3 | $4.57M | Buy |
60,408
+1,733
| +3% | +$119K | 0.16% | 127 |
|
|
2019
Q2 | $4.27M | Sell |
58,675
-415
| -0.7% | -$32.6K | 0.16% | 126 |
|
|
2019
Q1 | $4.76M | Sell |
59,090
-43,870
| -43% | -$3.59M | 0.19% | 104 |
|
|
2018
Q4 | $9.49M | Buy |
102,960
+1,433
| +1% | +$126K | 0.51% | 42 |
|
|
2018
Q3 | $9.6M | Buy |
101,527
+2,047
| +2% | +$194K | 0.43% | 44 |
|
|
2018
Q2 | $9.22M | Buy |
99,480
+19,371
| +24% | +$1.89M | 0.51% | 33 |
|
|
2018
Q1 | $7.33M | Sell |
80,109
-12,873
| -14% | -$1.41M | 0.45% | 36 |
|
|
2017
Q4 | $8.99M | Buy |
92,982
+90,371
| +3,461% | +$8.52M | 0.54% | 31 |
|
|
2017
Q3 | $292K | Buy |
+2,611
| New | +$199K | 0.02% | 183 |
|
Other funds holding ABBV
VCM
VPM
CAPTRUST Financial Advisors's ABBV Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its AbbVie (ABBV) stake by 15% in Q1 2026, buying an estimated $49.6M and bringing the position to 1,711,395 shares worth $372M. The position accounts for 0.65% of the portfolio, ranked #25.
CAPTRUST Financial Advisors first reported a position in ABBV in Q3 2017 and has held it in 35 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- CAPTRUST Financial Advisors held 1,711,395 shares of AbbVie worth $372M as of Q1 2026.
- CAPTRUST Financial Advisors bought 223,446 AbbVie shares in Q1 2026, an estimated $49.6M.
- AbbVie made up 0.65% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #25 holding.
- CAPTRUST Financial Advisors first reported a position in AbbVie in Q3 2017 and has held it in 35 quarters since.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.